Description
A sphingolipid; plasma levels correlate with hepatic steatosis severity in HCV patients; decreases in T-47D mammary epithelial cells and increased in MDA-MB-231 breast cancer cells relative to C16 sphingomyelin
Formal name: (7S)-4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-aza-4-phosphatriacontan-1-aminium, 4-oxide, inner salt
Synonyms: N-docosanoyl-D-erythro-Sphingosylphosphorylcholine|SM(d18:1/22:0)|Sphingomyelin (d18:1/22:0)
Molecular weight: 787.2
CAS: 94359-12-3
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Metabolic Diseases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Lipid Biochemistry|Sphingolipids